In this Healio Video Perspective from Hawaiian Eye 2025, Riad Sherif, MD, CEO of Oculis, discusses data on OCS-05 for the ...

In this study, we evaluated the progression of DR neurodegeneration, considering ganglion cell+inner plexiform layers ... or center involved macular edema (CSME) defined by the ETDRS group as retinal ...

The retina consists on 3 nuclear layers: (I) tanner nuclear layer which consists of ganglion ... provoked a macular edema 1 year after surgery (Mandai et al., 2017a), while a Japanese Phase I Trial of ...

When the blood glucose is higher than normal, it is known to damage nerve cells and blood vessels in the body ... eye due to abnormal blood vessels growing out of the retina. Diabetic macular edema: ...

Postoperative VFD was frequently observed nasally (86.4%, p=0.002), and on optical coherence tomography measurements, ganglion cell layer ... of the retina after ILM peeling towards the optic disc, as ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ...

Feb. 6, 2025 — The FDA has approved a new implantable treatment for adults with diabetic macular edema (DME) after studies showed that it could help maintain vision with as few as two ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema. Susvimo is the first and only ...